Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Sweta Chekuri, Aaron W. Aday(Vanderbilt University Medical Center), Maria M. Brooks, Bridget‐Anne Kirwan, Lucy Z. Kornblith(San Francisco General Hospital), Scott Berry(Queen's University), Mary Cushman(University of Vermont), Brett L. Houston(CancerCare Manitoba), Matthew D. Neal(University of Pittsburgh), Lindsay Bond, Patrick R. Lawler(McGill University Health Centre), Ewan C. Goligher(University Health Network), Arthur S. Slutsky(St. Michael's Hospital), Henny H. Billett(Albert Einstein College of Medicine), Harmony R. Reynolds(Anna Needs Neuroblastoma Answers), Lana A. Castellucci, Meredith Buxton(Center for Effective Global Action), Marc Carrier(University of Ottawa), Elizabeth Lorenzi(Berry & Associates (United States)), Anthony Gordon(University of Copenhagen), Marc J. M. Bonten(Utrecht University), Michelle N. Gong, Shailesh Bihari, Roger Lewis(University of California, Los Angeles), Alisa M. Higgins(Monash University), David T. Huang(University of Pittsburgh), Diptesh Aryal, Jorge Escobedo, Djillali Annane(Hôpital Raymond-Poincaré), Alexis F. Turgeon(Université Laval), Bryan J. McVerry(University of Pittsburgh), Susan R. Kahn(Jewish General Hospital), Keri S. Kim, Charlotte Bradbury(University of Bristol), Jeffrey S. Berger(New York University), Farah Al-Beidh(Imperial College Healthcare NHS Trust), Zoe McQuilten, Anand Kumar(All India Institute of Medical Sciences), Lindsay R. Berry(Berry & Associates (United States)), Yaseen M. Arabi(King Saud bin Abdulaziz University for Health Sciences), Zahra Bhimani(St. Michael's Hospital), Adrian Buzgau(Monash University), Robert S Rosenson, Frank Brunkhorst(Jena University Hospital), José Carlos Nicolau(Hospital São Paulo), Abi Beane(University of Oxford)
Bristol Research (University of Bristol)
August 26, 2021
Cited by 589


Related Papers